Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
TIBO
Description:
TIBO refers to a family of non-nucleoside inhibitors of HIV-1 reverse transcriptase investigated as antiviral compounds.
Primary topic:
HIV/AIDS drug development and treatment (58%)
Related topics:
HIV/AIDS drug development and treatment (58%),
Computational Drug Discovery Methods (13%)
OpenAlex ID:
keywords/tibo
Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral Drugs
1997
·
M Witvrouw
, E De Clercq
·
General Pharmacology The Vascular System
·
593
Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase
1994
·
Chris Tantillo
, Jianping Ding
, et al.
·
Journal of Molecular Biology
·
584
HIV Inhibitors Targeted at the Reverse Transcriptase
1992
·
Erik de Clercq
·
AIDS Research and Human Retroviruses
·
287
Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant
1996
·
Kalyan Das
, Jianping Ding
, et al.
·
Journal of Molecular Biology
·
202
A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site
1991
·
Joe C. Wu
, Thomas C. Warren
, et al.
·
Biochemistry
·
188
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2
1991
·
Michael J. Kukla
, Henry J. Breslin
, et al.
·
Journal of Medicinal Chemistry
·
177
HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse Transcriptase
1993
·
Jan Balzarini
, Anna Karlsson
, et al.
·
Virology
·
160
Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and x-ray structure investigations
1993
·
Wolfgang Schaefer
, Walter Gunar Friebe
, et al.
·
Journal of Medicinal Chemistry
·
129
Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors: Past, Present, and Future Perspectives
2002
·
Giuseppe Campiani
, Anna Ramunno
, et al.
·
Current Pharmaceutical Design
·
126
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 “- (4”-amino-1“,2”-oxathiole-2“,2”-dioxide)thymine (TSAO-T).
1992
·
J Balzarini
, M.J. Pérez-Pérez
, et al.
·
Journal of Biological Chemistry
·
123
From 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to Etravirine (TMC125): Fifteen Years of Research on Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
2005
·
Bart L. De Corte
·
Journal of Medicinal Chemistry
·
110
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy
1993
·
J Balzarini
, A Karlsson
, et al.
·
Journal of Virology
·
109
PCR amplification of DNA containing non-standard base pairs by variants of reverse transcriptase from Human Immunodeficiency Virus-1
2004
·
A. M. Sismour
, Stefan Lutz
, et al.
·
Nucleic Acids Research
·
105
Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1
1994
·
Christiane Moog
, Alexander Wick
, et al.
·
Antiviral Research
·
96
The discovery of antiviral agents: Ten different compounds, ten different stories
2008
·
Erik De Clercq
·
Medicinal Research Reviews
·
92
Prediction of Binding Affinities for TIBO Inhibitors of HIV-1 Reverse Transcriptase Using Monte Carlo Simulations in a Linear Response Method
1998
·
Richard H. Smith,
, William L. Jorgensen
, et al.
·
Journal of Medicinal Chemistry
·
89
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.
1993
·
J Balzarini
, A Karlsson
, et al.
·
Proceedings of the National Academy of Sciences
·
82
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase
1994
·
P L Boyer
, J Ding
, et al.
·
Antimicrobial Agents and Chemotherapy
·
76
Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant Virus
1993
·
Jan Balzarini
, Anna Karlsson
, et al.
·
Virology
·
71
Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
1993
·
J Balzarini
, A Karlsson
, et al.
·
Molecular Pharmacology
·
64
Molecular modeling studies of HIV‐1 reverse transcriptase nonnucleoside inhibitors: Total energy of complexation as a predictor of drug placement and activity
1995
·
Marilyn B. Kroeger Smith
, Stephen H. Hughes
, et al.
·
Protein Science
·
63
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
1994
·
J Balzarini
, A Karlsson
, et al.
·
Proceedings of the National Academy of Sciences
·
48
Design and Synthesis of Novel Inhibitors of HIV-1 Reverse Transcriptase
1995
·
Helena Maruenda
, Francis Johnson
·
Journal of Medicinal Chemistry
·
44
Crystallographic Analysis of the Binding Modes of Thiazoloisoindolinone Non-Nucleoside Inhibitors to HIV-1 Reverse Transcriptase and Comparison with Modeling Studies
1999
·
Jingshan Ren
, Robert M. Esnouf
, et al.
·
Journal of Medicinal Chemistry
·
43
Dancing with chemical formulae of antivirals: A personal account
2013
·
Erik De Clercq
·
Biochemical Pharmacology
·
42
Show more works
View as search
Works count:
101
Citation count:
4,354
Year
Topic
Type